Safety and biomarker effects of solanezumab in patients with Alzheimer's disease

Martin Farlow, Steven E. Arnold, Christopher H. Van Dyck, Paul S. Aisen, B. Joy Snider, Anton P. Porsteinsson, Stuart Friedrich, Robert A. Dean, Celedon Gonzales, Gopalan Sethuraman, Ronald B. Demattos, Richard Mohs, Steven M. Paul, Eric R. Siemers

Research output: Contribution to journalArticlepeer-review

212 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and biomarker effects of solanezumab in patients with Alzheimer's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences